Program Performance
Program volume is trending up — 403 cases reviewed across 45 sessions this year, with Breast Oncology leading in concordance. Overall concordance is 78%. 24 total items remain unresolved across all boards.
AI-generated · Updated 4/17/2026
Cases Reviewed
+100% vs prior period
Guideline Concordance
465 of 593 aligned
Median Days to Action
0% vs prior period
Documentation Rate
-31pp vs prior period
Audit metrics for coordination gaps — 1394 recommendations, 1940 tasks
0
Recs with no tasks created
0
Completed, not verified
9d
Median days to first touch
10d
Median days to verified completion
99
Currently blocked tasks
3d
Median blocked duration
0
Completed outside Arca
1.4
Avg tasks per recommendation
Dashed dot indicates partial month (current)
Top Modification Reasons
| Patient | Board | Recommendation | Owner | Days Overdue | Status |
|---|---|---|---|---|---|
| Kim, Barbara | Thoracic | Obtain brain MRI with contrast to evaluate for CNS metastases | Genetics Counselor | 189d | Needs Docs |
| Lopez, Thomas | Thoracic | Refer to thoracic surgery for mediastinoscopy and staging | Care Coordinator | 177d | Needs Docs |
| Okafor, Thomas | Thoracic | Start atezolizumab 1200mg IV q3w with carboplatin AUC 5 and etoposide 100mg/m2 | Interventional Radiology Coordinator | 175d | Needs Docs |
| Campbell, Angela | Thoracic | Schedule follow-up PET/CT in 12 weeks to assess treatment response | Care Coordinator | 173d | Needs Docs |
| Kim, Barbara | Thoracic | Begin gemcitabine 1000mg/m2 + nab-paclitaxel 125mg/m2 d1, d8, d15 q4w | Care Coordinator | 172d | Needs Docs |